menu
    • menu

    Company profile for Baylor College of Medicine

    NEW Drugs in Dev: 31
    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

    Virtual Booth

    Contact Supplier

    AbbVie Contract Manufacturing partners globally to develop, scale, and manufacture pharmaceutical products successfully.

    Virtual Booth

    Contact Supplier

    Topscience Biotech is a one-stop supplier of sodium hyaluronate//drug manufacturing license, CEP, GMP, DMF, and Form 41 certifications.

    Virtual Booth

    Contact Supplier

    Zach System is committed to providing Highly Customized Solutions for all your Development Programs.

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Baylor College of Medicine is committed to being a national leader in advancing human health through the integration of patient care, research, education and community service. We offer the opportunity to work in a challenging and stimulating environment with outstanding career opportunities and excellent benefits.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Baylor College of MedicineUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    One Baylor Plaza, Houston, Texas 77030
    Telephone
    Telephone
    (713)798-4951
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.bcm.edu/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    PEGS Boston Summit

    PEGS Boston Summit

    Not Confirmed

    envelop Contact Supplier

    PEGS Boston Summit

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Study Proposes Rethinking How HDAC Inhibitors Work in Cancer
    Study Proposes Rethinking How HDAC Inhibitors Work in Cancer

    07 Jun 2026

    // PRESS RELEASE

    https://www.bcm.edu/news/study-proposes-reconsidering-how-histone-deacetylase-inhibitors-work-in-cancer-treatment

    PRESS RELEASE
    07 Jun 2026
    Share Share
    Method Uncovers Cellular Composition In Metastatic Cancer Growth
    Method Uncovers Cellular Composition In Metastatic Cancer Growth

    28 Apr 2026

    // FIRSTWORD PHARMA

    https://firstwordpharma.com/story/7231303

    FIRSTWORD PHARMA
    28 Apr 2026
    Share Share
    Texas Children's Researcher Wins Alzheimer's Grant
    Texas Children's Researcher Wins Alzheimer's Grant

    25 Mar 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/texas-childrens-researcher-awarded-grant-to-advance-new-ways-to-prevent-and-treat-alzheimers-disease-302724902.html

    PR NEWSWIRE
    25 Mar 2026
    Share Share
    Fortitude Has Faith Glue Degraders Can Beat ADC Resistance
    Fortitude Has Faith Glue Degraders Can Beat ADC Resistance

    26 Jan 2026

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/fortitude-has-faith-molecular-glue-degraders-can-overcome-adc-resistance

    FIERCE BIOTECH
    26 Jan 2026
    Share Share
    GMA Spotlights Baylor's MAR-T Pancreatic Cancer Study
    GMA Spotlights Baylor's MAR-T Pancreatic Cancer Study

    26 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/26/3225492/0/en/Good-Morning-America-Features-Baylor-College-of-Medicine-Pancreatic-Cancer-Study-Utilizing-Marker-Therapeutics-MAR-T-Cell-Technology.html

    GLOBENEWSWIRE
    26 Jan 2026
    Share Share
    Baylor College Of Medicine Releases Positive Results
    Baylor College Of Medicine Releases Positive Results

    05 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/05/3212598/0/en/Baylor-College-of-Medicine-Publishes-Promising-Safety-and-Efficacy-Results-of-Multi-Antigen-Targeted-T-Cells-in-Patients-with-Pancreatic-Cancer.html

    GLOBENEWSWIRE
    05 Jan 2026
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search